Warning:  Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
 
Deprecated:  str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525 
  
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530 
 
Warning:  Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531 
   English Wikipedia
  Nephropedia Template TP (
  Twit Text
 
  DeepDyve Pubget Overpricing |    
 
  lüll Current treatment options for community-acquired methicillin-resistant  Staphylococcus aureus infection Moellering RC JrClin Infect Dis  2008[Apr]; 46 (7): 1032-7During the past decade, there has been a marked increase in the prevalence of  community-acquired methicillin-resistant Staphylococcus aureus infection in the  United States and elsewhere. The most common such infections are those involving  the skin and skin structures. Although a number of these lesions (including small  furuncles and abscesses) respond well to surgical incision and drainage, oral  antimicrobial agents are commonly used to treat these infections in outpatients.  Unfortunately, with the exception of linezolid, none of the agents presently  being used in this fashion has been subjected to rigorous clinical trial. Thus,  current therapy is based largely on anecdotal evidence. For more-serious  infections requiring hospitalization, parenteral antimicrobials such as  vancomycin, teicoplanin, daptomycin, linezolid, and tigecycline are presently  available and have demonstrated effectiveness in randomized, prospective,  double-blind trials.|*Methicillin Resistance[MESH]|Anti-Bacterial Agents/administration & dosage/*therapeutic use[MESH]|Community-Acquired Infections/*drug therapy/microbiology[MESH]|Humans[MESH]|Staphylococcal Infections/*drug therapy/microbiology[MESH]|Staphylococcal Skin Infections/*drug therapy/microbiology[MESH]|Staphylococcus aureus/*isolation & purification[MESH]|United States[MESH] |